Skip to main content

Table 3 Univariable and multivariable cox regression models predicting CSS and OS of 265 patients with UTUC after radical nephroureterectomy

From: Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study

Variable

CSS

OS

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

Age, continuous

1.01 (0.99–1.03)

0.282

0.99 (0.97–1.02)

0.641

1.03 (1.01–1.04)

0.011

1.02 (0.99–1.04)

0.159

Gender

 Male

1

0.681

1

0.93

1

0.827

1

0.66

 Female

1.11 (0.68–1.80)

 

1.03 (0.56–1.88)

 

1.05 (0.67–1.64)

 

0.89 (0.53–1.50)

 

Smoking

 No

1

0.171

1

0.302

1

0.113

1

0.119

 Yes

1.37 (0.87–2.14)

 

1.34 (0.77–2.36)

 

1.38 (0.93–2.04)

 

1.46 (0.91–2.34)

 

Previous hydronephrosis

 No

1

0.115

1

0.439

1

0.058

1

0.149

 Yes

1.47 (0.91–2.38)

 

1.30 (0.67–2.50)

 

1.51 (0.99–2.32)

 

1.51(0.86–2.65)

 

Previous bladder urothelial carcinoma

 No

1

0.606

1

0.833

1

0.926

1

0.966

 Yes

1.24 (0.54–2.86)

 

1.23 (0.37–3.48)

 

0.96 (0.42–2.19)

 

1.02 (0.39–2.69)

 

Concomitant bladder urothelial carcinoma

 No

1

0.636

1

0.712

1

0.48

1

0.411

 Yes

1.14 (0.66–1.97)

 

1.13 (0.60–2.14)

 

0.83 (0.49–1.41)

 

0.77 (0.42–1.43)

 

Laterality

 Left

1

0.512

1

0.11

1

0.772

1

0.23

 Right

0.87 (0.56–1.33)

 

1.50 (0.91–2.45)

 

0.95 (0.65–1.38)

 

1.30 (0.85–1.99)

 

Tumor location

 Renal pelvis

1

0.029

 

0.07

1

0.4

1

0.458

 Ureter

1.35 (0.85–2.15)

 

1.77 (0.93–3.37)

 

1.15 (0.77–1.72)

 

1.31 (0.76–2.25)

 

 Renal pelvis and ureter

2.61 (1.28–5.34)

 

2.69 (1.08–6.70)

 

1.62 (0.79–3.32)

 

1.63 (0.70–3.78)

 

Tumor size, continuous

1.13 (1.03–1.26)

0.015

1.07 (0.95–1.21)

0.268

1.09 (0.99–1.19)

0.083

1.05 (0.94–1.18)

0.364

Tumor focality

 Unifocal

1

0.07

1

0.871

1

0.085

1

0.694

 Multifocal

1.49 (0.97–2.28)

 

0.96 (0.58–1.60)

 

1.40 (0.96–2.04)

 

1.09 (0.70–1.70)

 

LVI

        

 No

1

< 0.001

1

0.003

1

< 0.001

1

0.002

 Yes

2.20 (1.54–3.13)

 

2.0 (1.26–3.17)

 

2.20 (1.50–3.23)

 

1.88 (1.25–2.83)

 

Tumor grade

 Low

1

< 0.001

 

< 0.001

1

< 0.001

1

0.001

 High

11.23 (4.89–25.81)

 

6.95 (2.87–16.83)

 

4.03 (2.47–6.56)

 

2.59 (1.50–4.49)

 

pT stage

 pT1

1

< 0.001

 

0.002

1

< 0.001

1

0.004

 pT2

1.91 (0.75–4.84)

 

1.69 (1.11–2.59)

 

1.36 (0.69–2.70)

 

1.40 (0.91–2.14)

 

 pT3/pT4

7.40 (3.55–15.43)

 

2.83 (1.20–6.66)

 

4.12 (2.43–6.99)

 

2.29 (1.21–4.36)

 

pN stage

 pN0

1

0.429

1

0.494

1

0.785

1

0.645

 pNx

0.84 (0.55–1.29)

 

0.84 (0.51–1.38)

 

0.95 (0.64–1.40)

 

0.90 (0.59–1.39)

 

Distal ureter management

 Extravesical

1

0.434

1

0.277

1

0.538

1

0.921

 Open intravesical

1.09 (0.65–1.85)

 

1.35 (0.75–2.41)

 

0.77 (0.49–1.22)

 

0.93 (0.57–1.52)

 

 Endoscopic

0.73 (0.36–1.48)

 

0.74 (0.30–1.84)

 

0.87 (0.50–1.50)

 

0.86 (0.41–1.82)

 

Adjuvant chemotherapy

 No

1

< 0.001

1

0.111

1

< 0.001

1

0.331

 Yes

2.93 (1.88–4.56)

 

1.54 (0.90–2.63)

 

2.13 (1.40–3.22)

 

1.28 (0.78–2.09)

 

Type of procedure

 ONU

1

0.191

1

0.444

1

0.909

1

0.17

 LNU

0.67 (0.37–1.22)

 

1.38 (0.61–3.13)

 

1.03 (0.65–1.63)

 

1.61 (0.82–3.17)

 
  1. Bold values indicate that P-value ≤ 0.05, and considered statistically significant. ONU open radical nephroureterectomy, LNU laparoscopic radical nephroureterectomy, UTUC upper tract urothelial carcinoma, LVI lymphovascular invasion, CSS cancer specific survival, OS overall survival, OR odds ratio, CI confidence interval